Blood test could predict pancreatic cancer outcomes
NCT ID NCT05052671
First seen Mar 09, 2026 · Last updated Apr 30, 2026 · Updated 6 times
Summary
This study is for people with pancreatic cancer that can be surgically removed. Researchers want to see if tiny pieces of tumor DNA found in the blood (ctDNA) can help predict how long patients live. The goal is to gather information that may lead to better tests and treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stephenson Cancer Center- Tulsa
NOT_YET_RECRUITINGTulsa, Oklahoma, 74104, United States
Contact
Contact Email: •••••@•••••
-
University of Oklahoma
RECRUITINGOklahoma City, Oklahoma, 73117, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.